Retatrutide 6mg

$179.50

6 mg

Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.

6 mg

Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product intormation available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed. qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

Key Benefits

Significant weight loss

Clinical trials have shown that retatrutide can lead to substantial weight loss, with participants losing an average of 15-24% of their body weight over 48 weeks.

 

Improved glycemic control

Retatrutide can help improve blood sugar levels in people with type 2 diabetes by increasing insulin sensitivity and reducing glucagon secretion.

 

Reduced cardiovascular risk factors

Studies have indicated that retatrutide may reduce blood pressure, cholesterol, and triglyceride levels.

 

Improved metabolic health

Retatrutide can improve metabolic parameters such as body composition, body fat percentage, and liver function.

 

Details

  • Chemical Formula: C223H343F3N46O70

  • Molecular Mass: 4731.33 g/mol

  • CAS Number: 2381089-83-2

  • Vial Size: 3.5 ml

  • Vial Contents: Lyophilized Powder

Additional Information

  • Intended Use: Designed for Research Purposes only.

  • Storage: Store the vial in a cool, dry place away from direct sunlight. Once reconstituted, keep refrigerated at 2-8°C.

  • Solubility: Reconstitute with bacteriostatic water for best results. BAC Water Sold Separately.

  • Shelf Life: The lyophilized form has a shelf life of 24 months when properly stored. Once reconstituted, refrigerate and use within 4-6 weeks. Peptides sold in powdered form.

  • Handling: Ensure sterile techniques are used to maintain the product’s integrity during research. Syringes Not Included.